LEADER 03606nam  22006015  450 
001 9910300188603321
005 20200629162934.0
010   $a1-4939-1501-0
024 7 $a10.1007/978-1-4939-1501-9
035   $a(CKB)3710000000239249
035   $a(EBL)1964980
035   $a(OCoLC)908083000
035   $a(SSID)ssj0001354338
035   $a(PQKBManifestationID)11732972
035   $a(PQKBTitleCode)TC0001354338
035   $a(PQKBWorkID)11327518
035   $a(PQKB)11320348
035   $a(DE-He213)978-1-4939-1501-9
035   $a(MiAaPQ)EBC1964980
035   $a(PPN)181348179
035   $a(EXLCZ)993710000000239249
100   $a20140913d2015      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aUpper Tract Urothelial Carcinoma /$fedited by Shahrokh F. Shariat, Evanguelos Xylinas
205   $a1st ed. 2015.
210  1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2015.
215   $a1 online resource (206 p.)
300   $aDescription based upon print version of record.
311   $a1-4939-1500-2 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aEpidemiology and risk factors for upper urinary urothelial cancers -- Diagnosis and Evaluation of Upper Tract Urothelial Carcinoma (UTUC) -- Upper Urinary Tract Urothelial Carcinoma Pathology -- Prognostics factors, molecular markers and predictive tools in upper tract urothelial carcinoma -- Conservative management of low-risk UTUC -- Surgical Management of High-risk Upper Tract Urothelial Carcinoma -- The Role of Lymphadenectomy in the Management of Urothelial Carcinoma of the Upper Urinary Tract -- Chemotherapy.
330   $aUpper Tract Urothelial Carcinoma represents the first book of its kind to be dedicated solely to UTUC. Its aim is to improve understanding and eventually care of a disease that is greatly understudied and underappreciated, yet commonly dealt with by many medical and urologic oncologists. The volume features new data regarding genetic susceptibility, gene expression studies and causative factors; contemporary concepts and controversies regarding diagnosis and staging of UTUC; prediction tools and their value in treatment decisions within each disease stage andpatient selection and treatment options such as endoscopic management, distal ureterectomy, radical nephroureterectomy and chemotherapy. Up-to-date information regarding boundaries of surgical resection, indication and extent of lymphadenectomy are covered as well as the role of perioperative/neoadjuvant chemotherapy in patients with high-risk UTUC.   Upper Tract Urothelial Carcinoma will be of great value to all Urologists, Medical Oncologists, and fellows in Urologic Oncology as well as upper level residents in training in Urology and Medical Oncology.
606   $aUrology
606   $aOncology  
606   $aUrology$3https://scigraph.springernature.com/ontologies/product-market-codes/H62002
606   $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160
615  0$aUrology.
615  0$aOncology  .
615 14$aUrology.
615 24$aOncology.
676   $a610
676   $a616.6
676   $a616994
702   $aShariat$b Shahrokh F$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aXylinas$b Evanguelos$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910300188603321
996   $aUpper Tract Urothelial Carcinoma$91761804
997   $aUNINA